Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hanover Insurance (THG) Cash & Equivalents (2016 - 2026)

Hanover Insurance filings provide 18 years of Cash & Equivalents readings, the most recent being $243.5 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 22.72% to $243.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $243.5 million, a 22.72% decrease, with the full-year FY2025 number at $1.1 billion, up 157.8% from a year prior.
  • Cash & Equivalents hit $243.5 million in Q1 2026 for Hanover Insurance, down from $1.1 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q4 2025 to a low of $145.9 million in Q2 2022.
  • Median Cash & Equivalents over the past 5 years was $294.5 million (2023), compared with a mean of $362.0 million.
  • Biggest five-year swings in Cash & Equivalents: tumbled 33.27% in 2023 and later soared 157.8% in 2025.
  • Hanover Insurance's Cash & Equivalents stood at $305.0 million in 2022, then increased by 3.64% to $316.1 million in 2023, then soared by 37.77% to $435.5 million in 2024, then soared by 157.8% to $1.1 billion in 2025, then crashed by 78.31% to $243.5 million in 2026.
  • The last three reported values for Cash & Equivalents were $243.5 million (Q1 2026), $1.1 billion (Q4 2025), and $915.7 million (Q3 2025) per Business Quant data.